Early experience of a transcatheter aortic valve program at a veterans affairs facility

JAMA Surgery

Volumn 148, Issue 12, 2013, Pages 1087-1093

  Omer, Shuab ^a,b   Kar, Biswajit ^a,b   Cornwell, Lorraine D ^a,b   Blaustein, Alvin ^a,b   Levine, Glen N ^a,b   Ali, Nadir ^a,b   Jneid, Hani ^a,b   Paniagua, David ^a,b   Atluri, Prasad V ^a,b   Bechara, Carlos F ^a,b   Kougias, Panos ^a,b   Ruma, Maryrose ^b   Preventza, Ourania ^a,c   Bozkurt, Biykem ^a,b   Carabello, Blase A ^a,b,c   Bakaeen, Faisal G ^a,b,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b MICHAEL E DEBAKEY VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c TEXAS HEART INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AORTA STENOSIS; ARTIFICIAL HEART PACEMAKER; ASSISTED CIRCULATION; CARDIOVASCULAR DISEASE; CEREBROVASCULAR ACCIDENT; CLINICAL ARTICLE; CONFERENCE PAPER; DIALYSIS; ENDOVASCULAR SURGERY; EXTRACORPOREAL OXYGENATION; FEMALE; HEALTH PROGRAM; HEART INFARCTION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; INGUINAL REGION; KIDNEY FAILURE; LENGTH OF STAY; MALE; MEDICAL RECORD REVIEW; MORBIDITY; PARAVALVULAR LEAK; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTHETIC VALVE ENDOCARDITIS; PUBLIC HOSPITAL; RISK ASSESSMENT; SURGICAL MORTALITY; TRANSCATHETER AORTIC VALVE IMPLANTATION; VASCULAR ACCESS; WOUND COMPLICATION;

EID: 84890714492     PISSN: 21686254     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamasurg.2013.3743     Document Type: Conference Paper

References (29)

1. Holmes DR Jr, Mack MJ, Kaul S, et al; American Heart Association; American Society of Echocardiography; European Association for Cardio-Thoracic Surgery; Heart Failure Society of America; Mended Hearts; Society of Cardiovascular Anesthesiologists; Society of Cardiovascular Computed Tomography; Society for Cardiovascular Magnetic Resonance. 2012 ACCF/AATS/SCAI/STS expert consensus document on transcatheter aortic valve replacement: developed in collaboration with the American Heart Association, American Society of Echocardiography, European Association for Cardio-Thoracic Surgery, Heart Failure Society of America, Mended Hearts, Society of Cardiovascular Anesthesiologists, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance. J Thorac Cardiovasc Surg. 2012;144(3):e29-e84. http://www.jtcvsonline.org/article/S0022-5223(12) 00281-4/abstract. Accessed August 3, 2013.
2. Bach DS, Cimino N, Deeb GM. Unoperated patients with severe aortic stenosis. J Am Coll Cardiol. 2007;50(20):2018-2019. (Pubitemid 350046335)
3. Bach DS, Siao D, Girard SE, Duvernoy C, McCallister BD Jr, Gualano SK. Evaluation of patients with severe symptomatic aortic stenosis who do not undergo aortic valve replacement: the potential role of subjectively overestimated operative risk. Circ Cardiovasc Qual Outcomes. 2009;2(6):533-539.
4. Bakaeen FG, Chu D, Ratcliffe M, et al. Severe aortic stenosis in a veteran population: treatment considerations and survival. Ann Thorac Surg. 2010;89(2):453-458.
5. Dua A, Dang P, Shaker R, Varadarajan P, Pai RG. Barriers to surgery in severe aortic stenosis patients with Class I indications for aortic valve replacement. J Heart Valve Dis. 2011;20(4):396-400.
6. Bakaeen FG, Chu D, de la Cruz KI, et al. Aortic valve replacement: mortality predictions of surgeons versus risk model. J Surg Res. 2010;163(1):1-6.
7. Mack M. Frailty and aortic valve disease. J Thorac Cardiovasc Surg. 2013;145(3)(suppl):S7-S10.
8. Kodali SK, Williams MR, Smith CR, et al; PARTNER Trial Investigators. Two-year outcomes after transcatheter or surgical aortic-valve replacement. N Engl J Med. 2012;366(18):1686-1695.
9. Bakaeen FG, Kar B, Chu D, et al. Establishment of a transcatheter aortic valve program and heart valve team at a Veterans Affairs facility. Am J Surg. 2012;204(5):643-648.
10. National Center for Veteran Analysis and Statistics (NCVAS), US Department of Veterans Affairs. Population tables. http://www.va.gov/VETDATA/ Veteran-Population.asp. Accessed August 7, 2013.
11. Bakaeen FG, Chu D, Huh J, Carabello BA. Is an age of 80 years or greater an important predictor of short-term outcomes of isolated aortic valve replacement in veterans? Ann Thorac Surg. 2010;90(3):769-774.
12. Chitsaz S, Jaussaud N, Chau E, et al. Operative risks and survival in veterans with severe aortic stenosis: surgery versus medical therapy. Ann Thorac Surg. 2011;92(3):866-872.
13. Centers for Disease Control and Prevention. Life expectancy. http://www.cdc.gov/nchs/fastats/lifexpec.htm. Accessed August 7, 2013.
14. Smith CR, Leon MB, Mack MJ, et al; PARTNER Trial Investigators. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364(23):2187-2198.
15. Godino C, Maisano F, Montorfano M, et al. Outcomes after transcatheter aortic valve implantation with both Edwards-SAPIEN and CoreValve devices in a single center: the Milan experience. JACC Cardiovasc Interv. 2010;3(11):1110-1121.
16. Hayashida K, Lefèvre T, Chevalier B, et al. Transfemoral aortic valve implantation new criteria to predict vascular complications. JACC Cardiovasc Interv. 2011;4(8):851-858.
17. Kahlert P, Al-Rashid F, Weber M, et al. Vascular access site complications after percutaneous transfemoral aortic valve implantation. Herz. 2009;34(5):398-408.
18. Kodali SK, O'Neill WW, Moses JW, et al. Early and late (one year) outcomes following transcatheter aortic valve implantation in patients with severe aortic stenosis (from the United States REVIVAL trial). Am J Cardiol. 2011;107(7):1058-1064.
19. Lefèvre T, Kappetein AP, Wolner E, et al; PARTNER EU Investigator Group. One year follow-up of the multi-centre European PARTNER transcatheter heart valve study. Eur Heart J. 2011;32(2):148-157.
20. Tamburino C, Capodanno D, Ramondo A, et al. Incidence and predictors of early and late mortality after transcatheter aortic valve implantation in 663 patients with severe aortic stenosis. Circulation. 2011;123(3):299-308.
21. Thomas M, Schymik G, Walther T, et al. Thirty-day results of the SAPIEN Aortic Bioprosthesis European Outcome (SOURCE) Registry: a European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation. 2010;122(1):62-69.
22. Wenaweser P, Pilgrim T, Roth N, et al. Clinical outcome and predictors for adverse events after transcatheter aortic valve implantation with the use of different devices and access routes. Am Heart J. 2011;161(6):1114-1124.
23. Nuis RJ, Van Mieghem NM, Schultz CJ, et al. Timing and potential mechanisms of new conduction abnormalities during the implantation of the Medtronic CoreValve System in patients with aortic stenosis. Eur Heart J. 2011;32(16):2067-2074.
24. Webb JG, Wood DA. Current status of transcatheter aortic valve replacement. J Am Coll Cardiol. 2012;60(6):483-492.
25. Toggweiler S, Humphries KH, Lee M, et al. 5-year outcome after transcatheter aortic valve implantation. J Am Coll Cardiol. 2013;61(4):413-419.
26. Reynolds MR, Magnuson EA, Wang K, et al; PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort B). Circulation. 2012;125(9):1102-1109.
27. Reynolds MR, Magnuson EA, Lei Y, et al; PARTNER Investigators. Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (cohort A). J Am Coll Cardiol. 2012;60(25):2683-2692.
28. Greason KL, Bresnahan JF, Sorajja P, Suri RM, Rihal CS, Mathew V. Transcatheter aortic valve insertion catastrophe in inoperable patients: should aortic valve replacement be denied? J Card Surg. 2013;28(4):336-338.
29. Subramanian S, Rastan AJ, Holzhey D, et al. Conventional aortic valve replacement in transcatheter aortic valve implantation candidates: a 5-year experience. Ann Thorac Surg. 2012;94(3):726-730.